Journal ArticleOpen Access
The Folic Acid and Creatine Trial: Treatment effects on arsenic metabolite concentrations in blood
Authors
Author Affiliations
Columbia University, Berkeley Public Health Division, University of California, Berkeley
Published InISEE Conference Abstracts
Year2022
Citations1
Abstract
Background and Aim. Arsenic exposure is a global issue. Inorganic As (InAs) undergoes methylation to monomethyl (MMAs) and dimethyl-arsenical species (DMAs); full methylation to DMAs facilitates urinary excretion and can reduce risk of adverse health outcomes. Folate and creatine influence one-carbon metabolism which provides methyl groups for As methylation. We investigated the effects of folic acid (FA) and/or creatine supplementation on As metabolites and primary (PMI: MMAs/InAs) and secondary (SMI: DMAs/MMAs) methylation indices in blood in Bangladeshi adults. Methods. In this double-blind, placebo-controlled trial, 622 participants (20% folate deficient) were randomized to receive FA (400 or 800 μg/day), 3 g creatine/day, 3 g creatine+400 μg FA/day, or placebo for 12 weeks. For the following 12 weeks, half of the FA…
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.